If you experience low blood sugar symptoms (shakiness, sweating, fast heartbeat, confusion), having glucose tablets on hand and knowing when to seek medical attention is critical
When Lilly presented retatrutides early Phase 2 numbers at a medical conference in 2023, a scientist in the room told The Atlantic the usually staid audience broke into spontaneous applause
The study found that fewer than 1% of eligible older adults were prescribed an anti-obesity GLP-1 RA medication (0.2% of Medicare-aged patients and 0.4% of patients aged 60-64)
The minute that [the FDA] decided that the shortage on these products had passedthat was the time for the FDA to be like, Look, unless you fit into one of these exceptions clearly, were going to be sending you warning letters, and then were going to be seizing your product. And that didnt happen, she said
But weight regain after stopping the medication is a real concern that merits discussion